Ferrous sulfate is a widely used iron supplement, usually recommended for the treatment of iron-deficiency anemia. This type of iron is easily absorbed by the body and is frequently prescribed by ...

A $10 billion deal will see Walgreens Boots Alliance go private as Sycamore Partners acquires the company. Michigan is home to more than 200 Walgreens locations. Michigan's pharmacy landscape soon ...

(Bloomberg) -- Walgreens Boots Alliance Inc. agreed to be purchased by Sycamore Partners for $10 billion, turning one of the oldest, most recognizable US drugstore chains into a private company.

Walgreens and Sycamore Partners are dealing a $10 billion deal Walgreens Boots Alliance Inc (NASDAQ:WBA) was last seen up 7.1% at $10.99, amid news the embattled drugstore giant is nearing a $10 ...

Walgreens Boots Alliance will be taken private by Sycamore Partners for $10 billion, the buyout firm said on Thursday, closing out nearly a century of trading on public markets for the US pharmacy ...

Drugstore chain Walgreens Boots Alliance Inc. is closing in on a roughly $10 billion deal to sell itself to Sycamore Partners, a private-equity firm, which would then take Walgreens private and ...

With Walgreens (NASDAQ:WBA) agreeing to a subpar M&A deal with private equity firm Sycamore Partners, CVS Health (NYSE:CVS) will soon become the only listed brick-and-mortar pharmacy chain ...

Walgreens suspended its dividend this year after announcing a drastic cut a year earlier. Previously, the company had an impressive dividend growth streak approaching 50 years. Poor financials and ...

Not much has gone right for Walgreens Boots Alliance WBA-0.27%decrease; red down pointing triangle in the past decade. Customers bought more and more household items online at sites such as ...

Shares of Walgreens Boots Alliance have lost about half their value in the past year, as the chain has faced pressure in its retail and pharmacy businesses. By Danielle Kaye Walgreens Boots ...

The company on Thursday said it inked a deal with private equity firm Sycamore Partners that will take it off the public market for an equity value of around $10 billion. Sycamore will pay $11. ...

Stefano Pessina spent half a century building a pharmacy behemoth that stretches almost three times further than the Roman empire ever did. Now he may have to watch it come apart. This week, the ...